4KS8
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 4ks8 by Molmil](/molmil-images/mine/4ks8) | PAK6 kinase domain in complex with sunitinib | Descriptor: | N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carbo xamide, Serine/threonine-protein kinase PAK 6 | Authors: | Gao, J, Boggon, T.J. | Deposit date: | 2013-05-17 | Release date: | 2013-09-11 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (1.95 Å) | Cite: | Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6. Plos One, 8, 2013
|
|
4KS7
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 4ks7 by Molmil](/molmil-images/mine/4ks7) | PAK6 kinase domain in complex with PF-3758309 | Descriptor: | ISOPROPYL ALCOHOL, PF-3758309, Serine/threonine-protein kinase PAK 6 | Authors: | Gao, J, Boggon, T.J. | Deposit date: | 2013-05-17 | Release date: | 2013-09-11 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (1.4 Å) | Cite: | Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6. Plos One, 8, 2013
|
|